Divide injection areas into zones : Mentally divide each approved injection area (abdomen, thighs, upper arms) into quadrants or sections
The clinical outcomes observed with branded products cannot be assumed to transfer to compounded versions, which may differ in manufacturing processes, quality controls, inactive ingredients, concentration, and stability
I think it was really hard for states and health plans to really determine what the health needs of the people who were remaining on the program were going to be, said Elizabeth Williams, a senior policy manager for Medicaid research with the health policy group Kaiser Family Foundation, or KFF
"The degree of mean weight reduction seen in SURMOUNT-2 has not been previously achieved in phase 3 trials for obesity or overweight and type 2 diabetes." Tirzepatide is a once-weekly GIP (glucose-dependent insulinotropic polypeptide) receptor and GLP-1 (glucagon-like peptide-1) receptor agonist
It's a slower ramp for better adherence
Thats really one that I dont know if thats true, but its a big concern in the back of my mind every time someone asks me about that